This fact sheet outlines the importance of tackling respiratory syncytial virus (RSV), the top cause of newborn lower respiratory infections worldwide. It highlights the need to prepare for incoming RSV interventions (including vaccines for maternal immunization and antibodies given at birth) and to work across vaccine and prenatal care arenas.
Corporate author(s): PATH
Publication date: June 2016
67 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- About PATH's work > Advancing technologies
- For advocates and policymakers > Maternal health
- Health technologies > Newborn health
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA